Your session is about to expire
← Back to Search
Study Summary
This trial seeks to understand how cannabis affects people living with HIV and its effects on the immune system. Results could inform policy and new treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 4 trial • 46 Patients • NCT03008005Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Is the FDA sanctioning cannabis therapy for those living with HIV/AIDS?
"The safety of Cannabis use amongst PWH has been assessed as a 1 due to the limited clinical data that exists regarding its efficacy and safety, which is typical for Phase 1 trials."
Are there any remaining available slots in this research project?
"Per the clinicaltrials.gov portal, this medical trial is not presently in search of participants. Initially posted on October 1st 2023 and updated as recently as September 5th 2023, it does not appear to be looking for candidates at this time; however there are 230 other studies recruiting patients currently."
Share this study with friends
Copy Link
Messenger